doi: 10.1038/srep18736 414 ElifaniFAmicoEPepeGCapocciLCastaldoSRosaPet al
Since the aim was to concentrate on the hypoglycemic efficacies of acarbose and DPP-4is, our included trials were narrowed down to monotherapy, while several CVO trials, such as the SAVOR-TIMI 53, TECOS, EXAMINE, and CARMELINA studies, had patients with long diabetes durations who were receiving combined hypoglycemic therapies (41)
Exendin-4 is a peptide that shares 53% sequence homology with human GLP-1 and can bind and activate GLP-1 receptors with similar potency to GLP-1RAs
Clin Pharmacokinet (2011) 50:8198
The Health and Human Services Department provides a list of health departments in each state
CCK interaction with estradiol in satiety control Cholecystokinin (CCK) is a key controller of meal-ending satiation in animals and humans (118121)